Androgen Deprivation Therapy (ADT), a standard intervention for advanced Prostate Cancer (PCa), could effectively reduce androgen levels or block androgen receptor signaling, effectively suppressing tumor growth and progression. This evidence concerns the gene AR and prostate cancer.